The North America Motion Sickness Treatment Market would witness market growth of 2.5% CAGR during the forecast period (2023-2029).
The market's growth is anticipated to be propelled by untapped, emerging markets with high potential, owing to the presence of enhanced healthcare infrastructure, rising unmet healthcare demands, and a surge in need for efficient motion sickness medication.
Furthermore, certain demographics may be more susceptible to motion sickness symptoms, such as expectant mothers and individuals between the ages of 2 and 12. The initial indications of motion sickness encompass queasiness, heightened salivation, burping, perspiration, hyperventilation, and a general sense of discomfort. Motion sickness can be prevented or treated through pharmacological therapies such as anticholinergic drugs, antihistaminic drugs, and various other medications.
The North American over-the-counter drugs sector is experiencing growth due to the rising trend of individuals choosing OTC drugs for minor complications instead of seeking intensive treatment from healthcare professionals. This trend is particularly prevalent in countries such as the U.S., Canada, and Mexico. Furthermore, the emergence of numerous mid-size and small players in the region has led to the introduction of innovative medications at reduced prices, thereby enhancing the over-the-counter drugs sector in the region. The wider usage of OTC, like antihistamines, by general consumers for various minor health issues like motion sickness is expected to propel the motion sickness treatment market growth in the region.
The US market dominated the North America Motion Sickness Treatment Market by Country in 2022; thereby, achieving a market value of $131.6 Million by 2029. The Canada market is poised to grow at a CAGR of 4.5% during (2023 - 2029). Additionally, The Mexico market would witness a CAGR of 4.3% during (2023 - 2029).
Based on Drug Class, the market is segmented into Antihistamines, Anticholinergics and Others. Based on Route of Administration, the market is segmented into Oral and Others. Based on Distribution Channel, the market is segmented into Drug Store & Retail Pharmacies, Hospital Pharmacies and Online Pharmacies. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Worldwide Motion Sickness Treatment Market is Projected to reach USD 481 Million by 2029, at a CAGR of 3.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Viatris, Inc., Teva Pharmaceutical Industries Ltd., Amneal Pharmaceuticals, Inc., Baxter International, Inc., Novartis AG, Abbott Laboratories, Sun Pharmaceutical Industries Ltd., Zydus Lifesciences Ltd., Prestige Consumer Healthcare, Inc., WellSpring Pharmaceutical Corporation (Avista Capital Partners).
Scope of the Study
Market Segments Covered in the Report:
By Drug Class
- Antihistamines
- Anticholinergics
- Others
By Route of Administration
By Distribution Channel
- Drug Store & Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Viatris, Inc.
- Teva Pharmaceutical Industries Ltd.
- Amneal Pharmaceuticals, Inc.
- Baxter International, Inc.
- Novartis AG
- Abbott Laboratories
- Sun Pharmaceutical Industries Ltd.
- Zydus Lifesciences Ltd.
- Prestige Consumer Healthcare, Inc.
- WellSpring Pharmaceutical Corporation (Avista Capital Partners)
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Motion Sickness Treatment Market, by Drug Class
1.4.2 North America Motion Sickness Treatment Market, by Route of Administration
1.4.3 North America Motion Sickness Treatment Market, by Distribution Channel
1.4.4 North America Motion Sickness Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Motion Sickness Treatment Market by Drug Class
3.1 North America Antihistamines Market by Country
3.2 North America Anticholinergics Market by Country
3.3 North America Others Market by Country
Chapter 4. North America Motion Sickness Treatment Market by Route of Administration
4.1 North America Oral Market by Country
4.2 North America Others Market by Country
Chapter 5. North America Motion Sickness Treatment Market by Distribution Channel
5.1 North America Drug Store & Retail Pharmacies Market by Country
5.2 North America Hospital Pharmacies Market by Country
5.3 North America Online Pharmacies Market by Country
Chapter 6. North America Motion Sickness Treatment Market by Country
6.1 US Motion Sickness Treatment Market
6.1.1 US Motion Sickness Treatment Market by Drug Class
6.1.2 US Motion Sickness Treatment Market by Route of Administration
6.1.3 US Motion Sickness Treatment Market by Distribution Channel
6.2 Canada Motion Sickness Treatment Market
6.2.1 Canada Motion Sickness Treatment Market by Drug Class
6.2.2 Canada Motion Sickness Treatment Market by Route of Administration
6.2.3 Canada Motion Sickness Treatment Market by Distribution Channel
6.3 Mexico Motion Sickness Treatment Market
6.3.1 Mexico Motion Sickness Treatment Market by Drug Class
6.3.2 Mexico Motion Sickness Treatment Market by Route of Administration
6.3.3 Mexico Motion Sickness Treatment Market by Distribution Channel
6.4 Rest of North America Motion Sickness Treatment Market
6.4.1 Rest of North America Motion Sickness Treatment Market by Drug Class
6.4.2 Rest of North America Motion Sickness Treatment Market by Route of Administration
6.4.3 Rest of North America Motion Sickness Treatment Market by Distribution Channel
Chapter 7. Company Profiles
7.1 Viatris, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental Analysis
7.1.4 Research & Development Expense
7.2 Teva Pharmaceutical Industries Ltd.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expenses
7.3 Amneal Pharmaceuticals, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental Analysis
7.3.4 Research & Development Expenses
7.4 Baxter International, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental Analysis
7.4.4 Research & Development Expense
7.5 Novartis AG
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.6 Abbott Laboratories
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 SWOT Analysis
7.7 Sun Pharmaceutical Industries Ltd.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expenses
7.8 Zydus Lifesciences Ltd.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Trials and Approvals:
7.9 Prestige Consumer Healthcare, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.10. WellSpring Pharmaceutical Corporation (Avista Capital Partners)
7.10.1 Company Overview
TABLE 1 North America Motion Sickness Treatment Market, 2019 - 2022, USD Million
TABLE 2 North America Motion Sickness Treatment Market, 2023 - 2029, USD Million
TABLE 3 North America Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 4 North America Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
TABLE 5 North America Antihistamines Market by Country, 2019 - 2022, USD Million
TABLE 6 North America Antihistamines Market by Country, 2023 - 2029, USD Million
TABLE 7 North America Anticholinergics Market by Country, 2019 - 2022, USD Million
TABLE 8 North America Anticholinergics Market by Country, 2023 - 2029, USD Million
TABLE 9 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 10 North America Others Market by Country, 2023 - 2029, USD Million
TABLE 11 North America Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
TABLE 12 North America Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
TABLE 13 North America Oral Market by Country, 2019 - 2022, USD Million
TABLE 14 North America Oral Market by Country, 2023 - 2029, USD Million
TABLE 15 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 16 North America Others Market by Country, 2023 - 2029, USD Million
TABLE 17 North America Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 18 North America Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 19 North America Drug Store & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 20 North America Drug Store & Retail Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 21 North America Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 22 North America Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 23 North America Online Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 24 North America Online Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 25 North America Motion Sickness Treatment Market by Country, 2019 - 2022, USD Million
TABLE 26 North America Motion Sickness Treatment Market by Country, 2023 - 2029, USD Million
TABLE 27 US Motion Sickness Treatment Market, 2019 - 2022, USD Million
TABLE 28 US Motion Sickness Treatment Market, 2023 - 2029, USD Million
TABLE 29 US Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 30 US Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
TABLE 31 US Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
TABLE 32 US Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
TABLE 33 US Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 34 US Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 35 Canada Motion Sickness Treatment Market, 2019 - 2022, USD Million
TABLE 36 Canada Motion Sickness Treatment Market, 2023 - 2029, USD Million
TABLE 37 Canada Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 38 Canada Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
TABLE 39 Canada Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
TABLE 40 Canada Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
TABLE 41 Canada Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 42 Canada Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 43 Mexico Motion Sickness Treatment Market, 2019 - 2022, USD Million
TABLE 44 Mexico Motion Sickness Treatment Market, 2023 - 2029, USD Million
TABLE 45 Mexico Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 46 Mexico Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
TABLE 47 Mexico Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
TABLE 48 Mexico Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
TABLE 49 Mexico Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 50 Mexico Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 51 Rest of North America Motion Sickness Treatment Market, 2019 - 2022, USD Million
TABLE 52 Rest of North America Motion Sickness Treatment Market, 2023 - 2029, USD Million
TABLE 53 Rest of North America Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 54 Rest of North America Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
TABLE 55 Rest of North America Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
TABLE 56 Rest of North America Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
TABLE 57 Rest of North America Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 58 Rest of North America Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 59 key information – Viatris, Inc.
TABLE 60 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 61 Key Information – Amneal Pharmaceuticals, INc.
TABLE 62 Key Information – Baxter International, Inc.
TABLE 63 Key Information – Novartis AG
TABLE 64 Key Information – Abbott Laboratories
TABLE 65 Key Information – Sun Pharmaceutical Industries Ltd.
TABLE 66 Key Information – Zydus Lifesciences Ltd.
TABLE 67 Key Information – Prestige consumer healthcare inc.
TABLE 68 Key Information – WellSpring Pharmaceutical Corporation
List of Figures
FIG 1 Methodology for the research
FIG 2 Swot analysis: Abbott laboratories